The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between up-front surgery and risk of stroke in U.S. veterans with oropharyngeal squamous cell carcinoma.
 
Lova Sun
Consulting or Advisory Role - HMP; MJH Life Sciences; Regeneron
 
Robert Brody
No Relationships to Disclose
 
Danielle Candelieri
No Relationships to Disclose
 
Tori Anglin-Foote
No Relationships to Disclose
 
Julie Ann Lynch
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); CardioDx (Inst); Genomic Health (Inst); Janssen (Inst); Myriad Genetics (Inst)
 
Ryan Hausler
No Relationships to Disclose
 
Kara Noelle Maxwell
No Relationships to Disclose
 
Scott Damrauer
Consulting or Advisory Role - Calico
Research Funding - Renalytix AI; Renalytix AI
 
Eric Ojerholm
No Relationships to Disclose
 
John Nicholas Lukens
Research Funding - Merck (Inst)
 
Roger B. Cohen
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Cantargia AB; Coherus Biosciences; Fstar Therapeutics; Heat Biologics; Xencor
Research Funding - AstraZeneca (Inst); Celldex (Inst); Codiak Biosciences (Inst); F-Star Biotechnology (Inst); Genocea Biosciences (Inst); Heat Biologics (Inst); Innate Pharma (Inst); Macrogenics (Inst); Merck (Inst); Xencor (Inst)
 
Kelly D. Getz
No Relationships to Disclose
 
Rebecca A. Hubbard
Honoraria - Johnson & Johnson
Research Funding - Merck; Pfizer
 
Bonnie Ky
Honoraria - UpToDate
Consulting or Advisory Role - American College of Cardiology; Bioinvent; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Cytokinetics; Gilead Sciences; Mateon Therapeutics; Pfizer; Pfizer/NCCN; Roche; Roche
Speakers' Bureau - Bristol Myers Squibb
Research Funding - Pfizer; Pfizer; Roche; Singulex
Patents, Royalties, Other Intellectual Property - Have a patent on the use of neuregulin-1b as a biomarker in heart failure; Pending patent application on the use of IgE as a biomarker of cardiotoxicity